Table 1 Pooled, and stratified characteristics of hospitalized patients.
From: “Long COVID” results after hospitalization for SARS-CoV-2 infection
Characteristics | Pooled | Stratified | |
|---|---|---|---|
Patients n (%) | No supplemental oxygen or low-flow oxygen n (%) | HFNC or NIV or IMV | |
471 | 381 | 90 | |
Male, n (%) | 301 (63.8) | 225 (59.1) | 76 (84.4) |
Female, n (%) | 170 (36.2) | 156 (40.9) | 14 (15.6) |
Age, median (Q1–Q3) years | 71 (58–81) | 73 (57–82) | 67 (59–74) |
Age male, median (Q1–Q3) years | 68 (56–78) | 68 (56–79) | 67 (59–73) |
Age female, median (Q1–Q3) years | 76 (62–85) | 77 (63–86) | 65 (57–79) |
BCRSS at admission 0, n (%) | 226 (48.1) | 224 (58.8) | 2 (2.2) |
BCRSS at admission 1, n (%) | 112 (23.8) | 109 (28.6) | 3 (3.4) |
BCRSS at admission 2, n (%) | 47 (10.0) | 43 (11.3) | 4 (4.5) |
BCRSS at admission 3, n (%) | 45 (9.6) | 5 (1.3) | 40 (44.9) |
BCRSS at admission 4, n (%) | 38 (8.1) | 0 (0.0) | 38 (42.7) |
BCRSS at admission 5, n (%) | 2 (0.4) | 0 (0.0) | 2 (2.3) |
P/F ratio at admission, median (Q1–Q3) | 310 (191–368) | 333 (265–382) | 128 (93–175) |
P/F ratio < 300, n (%) | 218 (46.5) | 134 (35.3) | 84 (94.4) |
NEWS2 at admission, median (Q1–Q3) | 4 (2–7) | 3 (2–6) | 8 (6–9) |
NEWS2 0–4, n (%) | 258 (54.9) | 244 (64.0) | 14 (15.7) |
NEWS2 5–6, n (%) | 83 (17.7) | 68 (17.9) | 15 (16.9) |
NEWS2 ≥ 7, n (%) | 129 (27.4) | 69 (18.1) | 60 (67.4) |
Comorbidities | |||
Cardiovascular (including hyperension), n (%) | 289 (61.5) | 237 (62.2) | 52 (58.4) |
Diabetes, n (%) | 82 (17.4) | 67 (17.6) | 15 (16.9) |
Gastrointestinal, n (%) | 73 (15.5) | 56 (14.7) | 17 (19.1) |
Autoimmune, n (%) | 62 (13.2) | 55 (14.4) | 7 (7.9) |
Obesity, n (%) | 55 (11.7) | 37 (9.7) | 18 (20.2) |
Pulmonary, n (%) | 57 (12.1) | 48 (12.6) | 9 (10.1) |
Renal, n (%) | 50 (10.6) | 41 (10.8) | 9 (10.1) |
Cancer, n (%) | 56 (11.9) | 49 (12.9) | 7 (7.9) |
Outcomes | |||
Intra-hospital mortality, n (%) | 58 (12.3) | 46 (12.1) | 12 (13.3) |
Length of stay, median (Q1–Q3) | 10 (6–16) | 9 (6–14) | 21 (13–33) |
Complications | 17 (4.5) | ||
Venous thromboembolism (pulmonary embolism–deep vein thrombosis), n (%) | 28 (6.0) | 8 (2.1) | 11 (12.4) |
Acute coronary syndrome, n (%) | 10 (2.1) | 15 (3.9) | 2 (2.2) |
Sepsis, n (%) | 24 (5.1) | 0 (0.0) | 9 (10.1) |
Guillian-Barrè syndrome, n (%) | 1 (0.2) | 1 (0.3) | 1 (1.1) |
Pneumothorax, n (%) | 4 (0.8) | 1 (0.3) | 3 (3.4) |
Pneumomediastinum, n (%) | 6 (1.3) | 17 (4.5) | 5 (5.6) |
